The haplotype analyses using multiple markers of the apolipoprotein B gene in patients with coronary artery disease

Journal of Korean Medical Science

Volumn 16, Issue 6, 2001, Pages 719-724

  Hong, Seung Ho ^a   Song, Junghan ^b   Kim, Jin Q ^b,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Seoul National University   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

Apolipoproteins B; Coronary Disease; Variation (Genetic)

Indexed keywords

APOLIPOPROTEIN B;

ADULT; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENETICS; HAPLOTYPE; HUMAN; KOREA; MALE;

ADULT; APOLIPOPROTEINS B; CORONARY ARTERIOSCLEROSIS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; HAPLOTYPES; HUMAN; KOREA; MALE; MIDDLE AGE; POLYMORPHISM (GENETICS); VARIATION (GENETICS);

EID: 0035650711     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2001.16.6.719     Document Type: Article

References (42)

1. Herbert, PN, Assmann G, Gotto AM Jr, Fredrickson DS. Familial lipoprotein deficiency: abetalipoproteinemia, hypobetalipoproteinemia, and Tangier disease. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS. eds. The Metabolic Basis of Inherited Disease. 5th ed. New York: McGraw-Hill Book Co., New York 1983: 587-621.
2. Brown MS, Goldstein JL. How LDL receptors influence cholesterol and atherosclerosis. Sci Am 1984; 251: 58-66.
3. Brunzell JD, Sniderman AD, Albers JJ, Kwiterovich PO Jr. Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis 1984; 4: 79-83.
4. Knott TJ, Pease RJ, Powell LM, Wallis SC Jr, Rall SC Jr, Innerarity TL, Blackhart B, Taylor WH, Marcel Y, Milne R, et al. Complete protein sequence and identification of structural domains of human apolipoprotein B. Nature 1986; 323: 734-8.
5. Kane JP. Apolipoprotein B: structural and metabolic heterogeneity. Annu Rev Physiol 1983; 45: 637-50.
6. Powell LM, Wallis SC, Pease RJ, Edwards YH, Knott TJ, Scott J. A novel form of tissue-specific RNA processing produces apolipoprotein B-48 in intestine. Cell 1987; 50: 831-40.
7. Chen SH, Habib G, Yang CY, Gu ZW, Lee BR, Weng SA, Silberman SR, Cai SJ, Deslypere JP, Rosseneu M, Gotto AM, Li WH, Chan L. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 1987; 238: 363-6.
8. Greeve J, Altkemper I, Dieterich JH, Greten H, Winder E. Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. J Lipid Res 1993; 34: 1367-83.
9. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning, A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press 1989; 2: 9.16-9.23.
10. Ludwig EH, McCarthy BJ. Haplotype analysis of the human apolipoprotein B mutation associated with familial defective apolipoprotein B100. Am J Hum Genet 1990; 47: 712-20.
11. Ludwig EH, Friedl W, McCarthy BJ. High-resolution analysis of a hypervariable region in the human apolipoprotein B gene. Am J Hum Genet 1989; 45: 458-64.
12. Thompson EA, Deeb S, Walker D, Motulsky AG. The detection of linkage disequilibrium between closely linked markers: RFLPs at the A1-CIII apolipoprotein genes. Am J Hum Genet 1988; 42: 113-24.
13. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
14. Botstein D, White RL, Skolnick M, Davis RW. Construction of a genetic linkage map in man using restriction fragment length polymorphism Am J Hum Genet 1980; 32: 314-31.
15. Hill WG, Robertson A. Linkage disequilibrium of finite populations. Theor Appl Genet 1968; 38: 226-31.
16. Hong SH, Lee CC, Kim JQ. Genetic variation of the apolipoprotein B gene in Korean patients with coronary artery disease. Mol Cells 1997; 7: 521-5.
17. Innerarity TC, Mahley RW, Weisgraber KH, Bersot TP, Krauss RM, Vega GL, Grundy SM, Friedl W, Davignon J, McCarthy BJ. Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res 1990; 31: 1337-49.
18. Pan JP, Chiang AN, Tai JJ, Wang SP, Chang MS. Restriction fragment length polymorphisms of apolipoprotein B gene in Chinese population with coronary heart disease. Clin Chem 1995; 41: 424-9.
19. Ye P, Chen B, Wang S. Association of polymorphisms of the apolipoprotein B gene with coronary heart disease in Han Chinese. Atherosclerosis 1995; 117: 43-50.
20. Choong ML, Sethi SK, Koay ES. Effects of intragenic variability at 3 polymorphic sites of the apolipoprotein B gene on serum lipids and lipoproteins in a multiethnic Asian population. Hum Biol 1999; 71: 381-97.
21. Hegele RA, Huang L-S, Herbert PN, Blum CB, Buring JE, Hennekens CH, Breslow JL. Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction N Engl J Med 1986; 315: 1509-15.
22. Ferns GA, Lanham J, Dieppe P, Galton DJ. A DNA polymorphism of an apoprotein gene associated with hypertriglyceridaemia of primary gout. Hum Genet 1988; 78: 55-9.
23. De Benedictis G, Leone O, Falcone E, Rose G, Brancati C, Carotenuto L. RFLPs of the apoB gene: comparative study between Greeks and southern Italian peoples. Hum Biol 1993; 65: 401-11.
24. De Benedictis G, Rose G, Mazzei R, Leone O, Crescibene L, Brancati C, Carotenuto L. EcoRI-RFLP of the Apo B gene: a study in a sample group from south Italy. Ann Hum Genet 1991; 55:103-13.
25. Priestley L, Knott T, Wallis S, Powell L, Pease R, Scott J. RFLP for the human apolipoprotein B gene: III; EcoRV. Nucleic Acids Res 1985; 13: 6791.
26. Stepanov VA, Puzyrev VP. Apolipoprotein B gene polymorphism in a Russian population. Hum Biol 1994; 66: 527-31.
27. Juvonen T, Savolainen MJ, Kairaluoma MI, Lajunen LH, Humphries SE, Kesaniem YA. Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease. J Lipid Res 1995; 36: 804-12.
28. Saha N, Tay JS, Heng CK, Humphries SE. DNA polymorphism of the apolipoprotein B gene are associated with obesity and serum lipids in healthy Indians in Singapore. Clin Genet 1993; 44: 113-20.
29. Priestley L, Knott T, Wallis S, Powell L, Pease R, Scott J. RFLP for the human apolipoprotein B gene: IV; MspI. Nucleic Acids Res 1985; 13: 6792.
30. Renges HH, Wile DB, McKeigue PM, Marmot MG, Humphries SE. Apolipoprotein B gene polymorphisms are associated with lipid levels in men of South Asian descent. Atherosclerosis 1991; 91: 267-75.
31. Saha N, Tay JS, Humphries SE. Apolipoprotein B-gene DNA polymorphisms (XbaI and EcoRI), serum lipids, and apolipoproteins in healthy Chinese. Genet Epidemiol 1992; 9: 1-10.
32. Saha N, Tong MC, Tay JS, Jeyaseelan K, Humphries SE. DNA polymorphisms of the apolipoprotein B gene in Chinese coronary artery disease patients. Clin Genet 1992; 42: 164-70.
33. Glisic S, Savic I, Alavantic D. Apolipoprotein B gene DNA polymorphisms (EcoRI and MspI) and serum lipid levels in the Serbian healthy population: interaction of rare alleles and smoking and cholesterol levels. Genet Epidemiol 1995; 12: 499-508.
34. Peacock R, Dunning A, Hamsten A, Tornvall P, Humphries S, Talmud P. Apolipoprotein B gene polymorphisms, lipoproteins and coronary atherosclerosis: a study of young myocardial infarction survivors and healthy population-based individuals. Atherosclerosis 1992; 92: 151-64.
35. Tikkanen MJ, Helio T. Genetic variants of apolipoprotein B: relation to serum lipid levels and coronary artery disease among the Finns. Ann Med 1992; 24: 357-61.
36. Pouliot MC, Despres JP, Dionne FT, Vohl MC, Moorjani S, Prud'homme D, Bouchard C, Lupien PJ. ApoB-100 gene EcoRI polymorphism. Relations to plasma lipoprotein changes associated with abdominal visceral obesity. Arterioscler Thtomb 1994; 14: 527-33.
37. Vohl MC, Tchernof A, Dionne FT, Moorjani S, Prud'homme D, Bouchard C, Nadeau A, Lupien PJ, Despres JP. The apoB-100 gene EcoRI polymorphism influences the relationship between features of the insulin resistance syndrome and the hyper-apoB and dense LDL phenotype in men. Diabetes 1996; 45: 1405-11.
38. Delghandi M, Thangarajah R, Nilsen M, Grimsgaard S, Bonaa KH, Tonstad S, Jorgensen L. DNA polymorphisms of the apolipoprotein B gene (XbaI, EcoRI, and MspI RFLPs) in Norwegians at risk of atherosclerosis and healthy controls. Acta Cardiol 1999; 54: 215-25.
39. Tybjaerg-Hansen A, Nordestgaard BG, Gerdes LU, Humphries SE. Variation of apolipoprotein B gene is associated with myocardial infarction and lipoprotein levels in Danes. Atherosclerosis 1991; 89: 69-81.
40. Zaman MM, Ikemoto S, Yoshiike N, Date C, Yokoyama T, Tanaka H. Association of apolipoprotein genetic polymorphisms with plasma cholesterol in a Japanese rural population. The Shibata study. Arterioscler Thromb Vasc Biol 1997; 17: 3495-504.
41. Friedl W, Ludwig EH, Paulweber B, Sandhofer F, McCarthy B. Hypervariability in a minisatellite 3′ of the apolipoprotein B gene in patients with coronary heart disease compared with normal controls. J Lipid Res 1990; 31: 659-65.
42. Alavantic D, Glisic S, Kandic I. APO B 3′ HVR polymorphism in healthy population: relationships to serum lipid levels. Genet Epidemiol 1998; 15: 113-22.